Published in J Clin Microbiol on May 01, 1999
Sorting out the new HSV type specific antibody tests. Sex Transm Infect (2001) 2.54
Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition. J Clin Microbiol (2002) 2.39
Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts. Clin Vaccine Immunol (2006) 0.95
Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women. J Clin Microbiol (2003) 0.93
Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol (2002) 0.90
Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies. Clin Diagn Lab Immunol (2000) 0.85
Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay. Clin Diagn Lab Immunol (2004) 0.84
Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2. J Clin Microbiol (2002) 0.84
Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses. Clin Diagn Lab Immunol (2000) 0.83
Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies. Clin Diagn Lab Immunol (2005) 0.81
Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV. PLoS One (2015) 0.81
Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan. J Epidemiol (2009) 0.79
Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89
Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59
Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med (1995) 4.03
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl (1990) 4.02
Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med (1992) 3.91
Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89
Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19
A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med (1989) 2.94
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med (1991) 2.12
Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol (1998) 2.10
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med (1991) 1.97
Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods (1992) 1.86
Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods (1987) 1.59
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol (1984) 1.48
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology (1985) 1.29
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis (1988) 1.29
Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis (1993) 1.21
The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology (1993) 1.20
Neonatal herpes simplex virus infections. J Med Virol (1993) 1.20
Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol (1988) 1.18
Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis (1991) 1.10
Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J Clin Microbiol (1991) 1.06
Neonatal herpes simplex virus infection. Clin Perinatol (1997) 0.98
Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology (1996) 0.96
Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol (1985) 0.95
Suitability and clinical application of a multiplex nested PCR assay for the diagnosis of herpes simplex virus infections. J Med Virol (1996) 0.90
Herpes simplex virus infection of the fetus and newborn. Pediatr Ann (1994) 0.82
Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J Gen Virol (1983) 3.06
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (1995) 2.04
Fatal cowpox-like virus infection transmitted by cat. Lancet (1990) 1.97
Acute hepatitis A in haemophiliacs. Lancet (1992) 1.96
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies. Z Immunitatsforsch Exp Klin Immunol (1971) 1.67
Type-specific surface antigens of cells infected with herpes simplex virus (1 and 2). Proc Soc Exp Biol Med (1971) 1.64
Detection of influenza A(H1N1)v virus by real-time RT-PCR. Euro Surveill (2009) 1.50
Analysis of Mycoplasma hyorhinis genome by use of restriction endonucleases and by electron microscopy. J Bacteriol (1982) 1.48
Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost (1996) 1.46
HIV-1 infection by artificial insemination. Lancet (1998) 1.44
Physical mapping of temperature-sensitive mutations of herpes simplex virus type 1 using cloned restriction endonuclease fragments. J Gen Virol (1983) 1.42
Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost (1994) 1.40
Animal poxviruses transmitted from cat to man: current event with lethal end. Zentralbl Veterinarmed B (1991) 1.29
Search for intrafamilial transmission of hepatitis C virus in hemophilia patients. Blood (1993) 1.22
Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J Gen Virol (1993) 1.19
The plaque-forming factor for mink lung cells present in cytomegalovirus and herpes-zoster virus stocks identified as Mycoplasma hyorhinis. J Gen Virol (1981) 1.11
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells. Virology (1984) 0.98
Herpes simplex virus infection generates large tandemly reiterated simian virus 40 DNA molecules in a transformed hamster cell line. J Virol (1987) 0.98
[Herpes simplex virus type 1 and 2 in various disease enities]. Dtsch Med Wochenschr (1967) 0.98
Nucleic acid hybridization for detection of herpes viruses in clinical specimens. J Med Virol (1986) 0.97
Detection and characterization of infectious DNA intermediates of a primary foamy virus. J Gen Virol (1986) 0.96
Herpes simplex virus-induced amplification of SV40 sequences in transformed Chinese hamster embryo cells. Int J Cancer (1983) 0.96
Thermosensitive UL9 gene function is required for early stages of herpes simplex virus type 1 DNA synthesis. J Gen Virol (1995) 0.95
Detection of human cytomegalovirus in urine by DNA-DNA and RNA-DNA hybridization. J Infect Dis (1986) 0.93
Molecular cloning and physical mapping of the tupaia herpesvirus genome. J Virol (1985) 0.91
Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2. Med Microbiol Immunol (1978) 0.91
The prevalence of antibody to parvovirus B19 in hemophiliacs and in the general population. Zentralbl Bakteriol (1996) 0.89
Acute HIV-1 infection in patients with hemophilia B treated with beta-propiolactone-UV-inactivated clotting factor. Thromb Haemost (1990) 0.89
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Dtsch Med Wochenschr (2007) 0.88
An adenovirus from Tupaia (tree shrew): growth of the virus, characterization of viral DNA, and transforming ability. Virology (1980) 0.88
[Rubella virus hemagglutination inhibition IgM antibodies: the method of absorption of IgG by staphylococcal protein A as compared with density gradient ultracentrifugation (author's transl)]. Zentralbl Bakteriol Orig A (1976) 0.87
The genetic diversification of the HIV type 1 gag p17 gene in patients infected from a common source. AIDS Res Hum Retroviruses (1995) 0.87
HSV- and chemical carcinogen-induced amplification of SV40 DNA sequences in transformed cells is cell-line-dependent. Int J Cancer (1985) 0.86
HIV-1 infection in a cohort of haemophilic patients. Arch Dis Child (1990) 0.86
Diagnosis of acute and latent varicella-zoster virus infections using the polymerase chain reaction. J Med Virol (1991) 0.86
Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology (1983) 0.86
Structure of simian virus 40 DNA replicated by herpes simplex virus type 1. Virology (2000) 0.85
Physical map of tupaia adenovirus DNA by cleavage with restriction endonucleases and partial denaturation. J Gen Virol (1980) 0.84
Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count. J Med Virol (1998) 0.83
Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS (1999) 0.83
Parvovirus B19 infection in pregnancy. Intervirology (1998) 0.83
Beta-propiolactone UV inactivated clotting factor concentrate is the source of HIV-infection of 8 hemophilia B patients: confirmed. Thromb Haemost (1995) 0.83
Detection of herpes simplex virus and adenovirus DNA by dot blot hybridization using in vitro synthesized RNA transcripts. J Virol Methods (1986) 0.83
Pathogenesis of genital herpes simplex virus infection in mice. IV. Quantitative aspects of viral latency. Med Microbiol Immunol (1986) 0.82
Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene. AIDS (1999) 0.82
Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B. J Viral Hepat (2013) 0.82
Parallel evolution in the V3 region of HIV type 1 after infection of hemophiliacs from a homogeneous source. AIDS Res Hum Retroviruses (1994) 0.81
Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany. Eur J Med Res (2004) 0.81
Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef. Arch Virol (1992) 0.81
Study on simian virus 40 DNA synthesis in herpes simplex virus-infected cells. Virology (1996) 0.81
Different mechanisms of protection by monoclonal and polyclonal antibodies during the course of herpes simplex virus infection. Intervirology (1991) 0.81
Differentiation of Herpes simplex virus serotypes 1 and 2 by DNA-DNA-Hybridization. Med Microbiol Immunol (1975) 0.81
[Basis of the effect of hyperimmunoglobin, vaccine antigen and Marboran on vaccine virus infection]. Monatsschr Kinderheilkd (1966) 0.81
[Diagnosis of acute virus infection using the IgM-fraction of patients sera (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1974) 0.81
[Varicella-zoster virus infection and the serologic determination of first-infection immunity]. Dtsch Med Wochenschr (1985) 0.80
Latent human herpesvirus-6 DNA is sparsely distributed in peripheral blood lymphocytes of healthy adults and patients with lymphocytic disorders. Med Microbiol Immunol (1991) 0.80
Tupaia herpesviruses: characterization and biological properties. Microbiologica (1982) 0.79
Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy. Eur J Med Res (1999) 0.79
The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice. Arch Virol (1993) 0.79
Herpes simplex virus-induced "rolling circle" amplification of SV40 DNA sequences in a transformed hamster cell line correlates with tandem integration of the SV40 genome. Virology (1989) 0.79
[Herpes genitalis and cervix carcinoma: a current problem in virus and cancer research]. Dtsch Med Wochenschr (1971) 0.78
Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains. Med Microbiol Immunol (1984) 0.78
Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction. Arch Virol (1990) 0.78
HIV-II infection with initial neurological manifestation. J Neurol (1988) 0.78
[UV inactivation of Herpes simplex viruses, types 1 and 2]. Zentralbl Bakteriol Orig A (1973) 0.78
Male-to-female transmission of HIV in a cohort of hemophiliacs--frequency, risk factors and effect of sexual counseling. Infection (1995) 0.78
[Use of sindbis virus as a means of checking complete elimination of unspecific inhibitors in the rubella hemagglutination inhibition test (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1972) 0.78
A related epitope is consistently present on glycoprotein C of herpes simplex virus type 1 and 2. Acta Virol (1991) 0.78
Natural history of HIV-infection in hemophiliacs: clinical, immunological, and virological findings. Klin Wochenschr (1989) 0.77
Diversification of HIV-1 strains after infection from a unique source. AIDS Res Hum Retroviruses (1993) 0.77
Herpes simplex virus-directed overreplication of chromosomal DNA physically linked to the simian virus 40 integration site of a transformed hamster cell line. Virology (1988) 0.77
Heterosexual transmission of HIV in hemophiliacs. Klin Wochenschr (1990) 0.77
The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice. Med Microbiol Immunol (1981) 0.77
Anti-lymphocyte antibodies in plasma of HIV-1-infected patients preferentially react with MHC class II-negative T cells and are linked to antibodies against gp41. Clin Exp Immunol (1994) 0.76
Transformation of rodent fibroblasts by herpes simplex virus: presence of morphological transforming region 1 (MTR 1) is not required for the maintenance of the transformed state. Int J Cancer (1992) 0.76
[Lethal animal pox virus infection in an atopic patient simulating variola vera]. Hautarzt (1991) 0.76
Experimental infection and the state of viral latency of adult tupaia with herpes simplex virus type 1 and 2 and infection of juvenile Tupaia with temperature-sensitive mutants of HSV Type 2. Arch Virol (1980) 0.76
Screening for amplification of specific DNA sequences in cultured mammalian cells. Anal Biochem (1985) 0.76
Two cases of severe obstructive pneumonia associated with an HKU1-like coronavirus. Eur J Med Res (2007) 0.75
Serum interferon levels in patients having radiotherapy for cervical carcinoma. Arch Gynecol (1983) 0.75
Epidemiologically closely related viruses from hemophilia B patients display high homology in two hypervariable regions of the HIV-1 env gene. AIDS Res Hum Retroviruses (1991) 0.75
Recurrent herpetic keratitis during topical acyclovir application. Eur J Ophthalmol (1993) 0.75
Inducible expression of herpes simplex virus type 1 glycoprotein C in NIH 3T3 cells. Zentralbl Bakteriol (1990) 0.75
[Virus latency in infections with herpesviridae. Herpes simplex and varicella zoster virus: pathogenesis, clinical consequences]. Fortschr Med (1989) 0.75
[Evaluation of electromyographic recordings in the detection of Duchenne's dystrophy carriers]. Neurol Neurochir Pol (1977) 0.75
In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count. Eur J Med Res (1998) 0.75
Elucidation of an HIV-1 transmission from mother to child in west Africa by sequence analysis. Zentralbl Bakteriol (1996) 0.75
[Humoral and cell-mediated immunity in herpes simplex virus infection]. Monatsschr Kinderheilkd (1991) 0.75
HIV colonizing peripheral blood monocytes follows lymphocytic isolates in shifting from NSI to SI genotype. Arch Virol (1996) 0.75
Opportunistic infections with coronavirus-like particles in patients infected with the human immunodeficiency virus? Zentralbl Bakteriol (1989) 0.75
Biological testing versus sequence analysis for determination of drug resistance of human immunodeficiency virus. Zentralbl Bakteriol (1996) 0.75